- Lazard, Inc. recently appointed Kathy Elsesser, a retired Goldman Sachs partner and current TPG director, to its Board of Directors, replacing long-serving director Andrew M. Alper.
- Her extensive background in advising on complex consumer, retail, and healthcare transactions, plus broad governance experience, may influence Lazard’s oversight of its advisory and asset management businesses.
- We’ll now examine how Lazard’s new board appointment, alongside its Warburg Pincus advisory role, shapes the company’s investment narrative.
Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
Lazard Investment Narrative Recap
To own Lazard, you need to be comfortable with a fee-based advisory and asset management model that can swing with deal activity, while offering some ballast from recurring management fees. The immediate catalyst remains how its advisory pipeline converts into revenues, with lumpy mandates like the Warburg Pincus engagement in focus. The biggest near term risk is earnings pressure from deal slowdowns and fee competition, and this latest board appointment does not materially change that.
The Warburg Pincus mandate is the most relevant recent announcement here, because it highlights how individual, high-profile sponsor deals can move sentiment and near term revenue expectations. While the Kathy Elsesser appointment strengthens governance depth in consumer, retail, and healthcare, investors will likely keep treating large transactions such as the US$3.6 billion Warburg deal as the clearer reference point for Lazard’s short term earnings sensitivity and deal flow resilience.
Yet investors should pay attention to how quickly revenue can fall if large mandates dry up and...
Read the full narrative on Lazard (it's free!)
Lazard's narrative projects $4.6 billion in revenue and $524.8 million in earnings by 2029. This requires 12.9% yearly revenue growth and an earnings increase of about $255 million from $269.9 million today.
Uncover how Lazard's forecasts yield a $52.62 fair value, a 27% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts already expected Lazard to reach about US$5.0 billion in revenue and US$653.7 million in earnings, so if you are weighing automation and fee pressure against these upbeat assumptions, this latest Warburg deal and board refresh could either reinforce or challenge that outlook depending on how you see the next few years unfolding.
Explore 4 other fair value estimates on Lazard - why the stock might be worth as much as 99% more than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Lazard research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Lazard research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Lazard's overall financial health at a glance.
Searching For A Fresh Perspective?
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
- Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.
- Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
- The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com